NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

December 29, 2005

Last Updated Date

March 19, 2008

Start Date ^†

October 2005

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

Complete list of historical versions of study NCT00271128 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward

Official Title ^†

NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward (BNP4EVER)

Brief Summary

Detailed Description

The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards. Patients will be consented and randomized to open or blinded NT-proBNP test performed within 90 minutes in a venous blood sample.

Evaluation of the ER diagnosis and final discharge diagnosis in admitted patients will be carried out in light of the NT-proBNP results.

Study Phase

Study Type ^†

Observational

Study Design ^†

Prospective

Condition ^†

Shortness of Breath
Acute Exacerbation

Intervention ^†

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Active, not recruiting

Estimated Enrollment ^†

500

Estimated Completion Date

September 2007

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Acute shortness of breath of unknown etiology as presentation to the emergency room
Possible acute exacerbation of known heart failure

Exclusion Criteria:

None -

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

Israel

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00271128

Responsible Party

Secondary IDs ^††

Study Sponsor ^†

Hillel Yaffe Medical Center

Collaborators ^††

Investigators ^†

Principal Investigator:

Simcha R Meisel, MD MSc

Hillel Yaffe Medical Center

Information Provided By

Hillel Yaffe Medical Center

Verification Date

December 2005

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.